91 related articles for article (PubMed ID: 33839273)
1. Prevalence and Predictors of Missed Dysplasia on Index Barrett's Esophagus Diagnosing Endoscopy in a Veteran Population.
Nguyen TH; Thrift AP; George R; Rosen DG; El-Serag HB; Ketwaroo GA
Clin Gastroenterol Hepatol; 2022 Apr; 20(4):e876-e889. PubMed ID: 33839273
[TBL] [Abstract][Full Text] [Related]
2. Practice patterns of surveillance endoscopy in a Veterans Affairs database of 29,504 patients with Barrett's esophagus.
El-Serag HB; Duan Z; Hinojosa-Lindsey M; Hou J; Shakhatreh M; Naik AD; Chen GJ; Street RL; Kramer JR
Gastrointest Endosc; 2012 Oct; 76(4):743-55. PubMed ID: 22985642
[TBL] [Abstract][Full Text] [Related]
3. Use of Appropriate Surveillance for Patients With Nondysplastic Barrett's Esophagus.
Tavakkoli A; Appelman HD; Beer DG; Madiyal C; Khodadost M; Nofz K; Metko V; Elta G; Wang T; Rubenstein JH
Clin Gastroenterol Hepatol; 2018 Jun; 16(6):862-869.e3. PubMed ID: 29432922
[TBL] [Abstract][Full Text] [Related]
4. Neoplasia Detection Rate in Barrett's Esophagus and Its Impact on Missed Dysplasia: Results from a Large Population-Based Database.
Dhaliwal L; Codipilly DC; Gandhi P; Johnson ML; Lansing R; Wang KK; Leggett CL; Katzka DA; Iyer PG
Clin Gastroenterol Hepatol; 2021 May; 19(5):922-929.e1. PubMed ID: 32707339
[TBL] [Abstract][Full Text] [Related]
5. Barrett's oesophagus with indefinite for dysplasia shows high rates of prevalent and incident neoplasia in a UK multicentre cohort.
Kopczynska M; Ratcliffe E; Yalamanchili H; Thompson A; Nimri A; Britton J; Ang Y
J Clin Pathol; 2023 Dec; 76(12):847-854. PubMed ID: 36150885
[TBL] [Abstract][Full Text] [Related]
6. Low Prevalence of Endoscopic Screening for Barrett's Esophagus in a Screening-Eligible Primary Care Population.
Eluri S; Reddy S; Ketchem CC; Tappata M; Nettles HG; Watts AE; Cotton CC; Dellon ES; Shaheen NJ
Am J Gastroenterol; 2022 Nov; 117(11):1764-1771. PubMed ID: 35971219
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and Predictors of Barrett's Esophagus After Negative Initial Endoscopy: Analysis From Two National Databases.
Dhaliwal L; Kamboj AK; Williams JL; Chandar AK; Sachdeva K; Gibbons E; Lansing R; Passe M; Perez JA; Avenir KLR; Martin SA; Leggett CL; Chak A; Falk GW; Wani S; Shaheen NJ; Kisiel JB; Iyer PG
Clin Gastroenterol Hepatol; 2024 Mar; 22(3):523-531.e3. PubMed ID: 37716614
[TBL] [Abstract][Full Text] [Related]
8. Multicenter, Prospective Trial of Nonendoscopic Biomarker-Driven Detection of Barrett's Esophagus and Esophageal Adenocarcinoma.
Moinova HR; Verma S; Dumot J; Faulx A; Iyer PG; Canto MI; Wang JS; Shaheen NJ; Thota PN; Aklog L; Willis JE; Markowitz SD; Chak A
Am J Gastroenterol; 2024 May; ():. PubMed ID: 38686933
[TBL] [Abstract][Full Text] [Related]
9. Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagus.
Khalaf N; Nguyen T; Ramsey D; El-Serag HB
Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1832-9.e6. PubMed ID: 24793026
[TBL] [Abstract][Full Text] [Related]
10. Patient experiences with surveillance endoscopy: a qualitative study.
Arney J; Hinojosa-Lindsey M; Street RL; Hou J; El-Serag HB; Naik AD
Dig Dis Sci; 2014 Jul; 59(7):1378-85. PubMed ID: 24500449
[TBL] [Abstract][Full Text] [Related]
11. Significant Reduction in the Diagnosis of Barrett's Esophagus and Related Dysplasia During the COVID-19 Pandemic.
Pokala SK; Williams JL; Holub JL; Calderwood AH; Dominitz JA; Iyer PG; Shaheen NJ; Wani S
Am J Gastroenterol; 2024 Feb; 119(2):251-261. PubMed ID: 37782262
[TBL] [Abstract][Full Text] [Related]
12. Gastric dysplasia in random biopsies: the influence of
Ferreira AI; Lima Capela T; Macedo Silva V; Xavier S; Boal Carvalho P; Magalhães J; Cotter J
Scand J Gastroenterol; 2024; 59(2):125-132. PubMed ID: 37872792
[TBL] [Abstract][Full Text] [Related]
13. Adherence to quality indicators and surveillance guidelines in the management of Barrett's esophagus: a retrospective analysis.
Westerveld D; Khullar V; Mramba L; Ayoub F; Brar T; Agarwal M; Forde J; Chakraborty J; Riverso M; Perbtani YB; Gupte A; Forsmark CE; Draganov P; Yang D
Endosc Int Open; 2018 Mar; 6(3):E300-E307. PubMed ID: 29507870
[TBL] [Abstract][Full Text] [Related]
14. Computer-aided characterization of early cancer in Barrett's esophagus on i-scan magnification imaging: a multicenter international study.
Hussein M; Lines D; González-Bueno Puyal J; Kader R; Bowman N; Sehgal V; Toth D; Ahmad OF; Everson M; Esteban JM; Bisschops R; Banks M; Haefner M; Mountney P; Stoyanov D; Lovat LB; Haidry R
Gastrointest Endosc; 2023 Apr; 97(4):646-654. PubMed ID: 36460087
[TBL] [Abstract][Full Text] [Related]
15. Missed Opportunities: the Timing and Frequency of Screening Colonoscopy in Patients That Develop Esophageal Adenocarcinoma.
McKay SC; DeSouza ML; Dunst CM; Reavis KM; Bradley DD; DeMeester SR
J Gastrointest Surg; 2023 Dec; 27(12):2711-2717. PubMed ID: 37932595
[TBL] [Abstract][Full Text] [Related]
16. Variation in proliferative and cell cycle markers in Barrett's esophagus in relation to circumferential and axial location in the esophagus.
Umar N; Alleyne L; Cheung D; Rees J; Trudgill C; Zanetto U; Muzaffar S; Trudgill N
Eur J Gastroenterol Hepatol; 2024 Mar; 36(3):306-312. PubMed ID: 38251437
[TBL] [Abstract][Full Text] [Related]
17. Stratification of Barrett's esophagus surveillance based on p53 immunohistochemistry: a cost effectiveness analysis by an international collaborative group.
Menon S; Norman R; Iyer P; Ragunath K
Endoscopy; 2024 May; ():. PubMed ID: 38698618
[TBL] [Abstract][Full Text] [Related]
18. Association between time from esophageal food impaction to endoscopy and adverse events.
Redd WD; McCallen JD; Xue Z; Kiran A; Barlowe TS; Reed CC; Eluri S; Dellon ES
Gastrointest Endosc; 2024 Apr; 99(4):525-536.e3. PubMed ID: 37951280
[TBL] [Abstract][Full Text] [Related]
19. Decrease in Mobility during the COVID-19 Pandemic and Its Association with Increase in Depression among Older Adults: A Longitudinal Remote Mobility Monitoring Using a Wearable Sensor.
Mishra R; Park C; York MK; Kunik ME; Wung SF; Naik AD; Najafi B
Sensors (Basel); 2021 Apr; 21(9):. PubMed ID: 33946664
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of an integrated treatment to address smoking cessation and anxiety/depressive symptoms among people living with HIV: Study protocol for a randomized controlled trial.
Garey L; Wirtz MR; Labbe AK; Zvolensky MJ; Smits JAJ; Giordano TP; Rosenfield D; Robbins GK; Levy DE; McKetchnie SM; Bell T; O'Cleirigh C
Contemp Clin Trials; 2021 Jul; 106():106420. PubMed ID: 33933667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
